Literature DB >> 23644382

Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer.

Ken-Ichi Takayama1, Kuniko Horie-Inoue, Shintaro Katayama, Takashi Suzuki, Shuichi Tsutsumi, Kazuhiro Ikeda, Tomohiko Urano, Tetsuya Fujimura, Kiyoshi Takagi, Satoru Takahashi, Yukio Homma, Yasuyoshi Ouchi, Hiroyuki Aburatani, Yoshihide Hayashizaki, Satoshi Inoue.   

Abstract

High-throughput techniques have identified numerous antisense (AS) transcripts and long non-coding RNAs (ncRNAs). However, their significance in cancer biology remains largely unknown. Here, we report an androgen-responsive long ncRNA, CTBP1-AS, located in the AS region of C-terminal binding protein 1 (CTBP1), which is a corepressor for androgen receptor. CTBP1-AS is predominantly localized in the nucleus and its expression is generally upregulated in prostate cancer. CTBP1-AS promotes both hormone-dependent and castration-resistant tumour growth. Mechanistically, CTBP1-AS directly represses CTBP1 expression by recruiting the RNA-binding transcriptional repressor PSF together with histone deacetylases. CTBP1-AS also exhibits global androgen-dependent functions by inhibiting tumour-suppressor genes via the PSF-dependent mechanism thus promoting cell cycle progression. Our findings provide new insights into the functions of ncRNAs that directly contribute to prostate cancer progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23644382      PMCID: PMC3680743          DOI: 10.1038/emboj.2013.99

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  Widespread occurrence of antisense transcription in the human genome.

Authors:  Rodrigo Yelin; Dvir Dahary; Rotem Sorek; Erez Y Levanon; Orly Goldstein; Avi Shoshan; Alex Diber; Sharon Biton; Yael Tamir; Rami Khosravi; Sergey Nemzer; Elhanan Pinner; Shira Walach; Jeanne Bernstein; Kinneret Savitsky; Galit Rotman
Journal:  Nat Biotechnol       Date:  2003-03-17       Impact factor: 54.908

Review 3.  PSF and p54(nrb)/NonO--multi-functional nuclear proteins.

Authors:  Yaron Shav-Tal; Dov Zipori
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

4.  PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.

Authors:  M Mathur; P W Tucker; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

5.  TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.

Authors:  Ken-ichi Takayama; Kuniko Horie-Inoue; Takashi Suzuki; Tomohiko Urano; Kazuhiro Ikeda; Tetsuya Fujimura; Satoru Takahashi; Yukio Homma; Yasuyoshi Ouchi; Satoshi Inoue
Journal:  Mol Endocrinol       Date:  2012-03-28

6.  p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

Authors:  J L Shenk; C J Fisher; S Y Chen; X F Zhou; K Tillman; L Shemshedini
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

7.  SMAD3 represses androgen receptor-mediated transcription.

Authors:  S A Hayes; M Zarnegar; M Sharma; F Yang; D M Peehl; P ten Dijke; Z Sun
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

8.  Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.

Authors:  L G Wang; L Ossowski; A C Ferrari
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

9.  The transcriptional landscape of the mammalian genome.

Authors:  P Carninci; T Kasukawa; S Katayama; J Gough; M C Frith; N Maeda; R Oyama; T Ravasi; B Lenhard; C Wells; R Kodzius; K Shimokawa; V B Bajic; S E Brenner; S Batalov; A R R Forrest; M Zavolan; M J Davis; L G Wilming; V Aidinis; J E Allen; A Ambesi-Impiombato; R Apweiler; R N Aturaliya; T L Bailey; M Bansal; L Baxter; K W Beisel; T Bersano; H Bono; A M Chalk; K P Chiu; V Choudhary; A Christoffels; D R Clutterbuck; M L Crowe; E Dalla; B P Dalrymple; B de Bono; G Della Gatta; D di Bernardo; T Down; P Engstrom; M Fagiolini; G Faulkner; C F Fletcher; T Fukushima; M Furuno; S Futaki; M Gariboldi; P Georgii-Hemming; T R Gingeras; T Gojobori; R E Green; S Gustincich; M Harbers; Y Hayashi; T K Hensch; N Hirokawa; D Hill; L Huminiecki; M Iacono; K Ikeo; A Iwama; T Ishikawa; M Jakt; A Kanapin; M Katoh; Y Kawasawa; J Kelso; H Kitamura; H Kitano; G Kollias; S P T Krishnan; A Kruger; S K Kummerfeld; I V Kurochkin; L F Lareau; D Lazarevic; L Lipovich; J Liu; S Liuni; S McWilliam; M Madan Babu; M Madera; L Marchionni; H Matsuda; S Matsuzawa; H Miki; F Mignone; S Miyake; K Morris; S Mottagui-Tabar; N Mulder; N Nakano; H Nakauchi; P Ng; R Nilsson; S Nishiguchi; S Nishikawa; F Nori; O Ohara; Y Okazaki; V Orlando; K C Pang; W J Pavan; G Pavesi; G Pesole; N Petrovsky; S Piazza; J Reed; J F Reid; B Z Ring; M Ringwald; B Rost; Y Ruan; S L Salzberg; A Sandelin; C Schneider; C Schönbach; K Sekiguchi; C A M Semple; S Seno; L Sessa; Y Sheng; Y Shibata; H Shimada; K Shimada; D Silva; B Sinclair; S Sperling; E Stupka; K Sugiura; R Sultana; Y Takenaka; K Taki; K Tammoja; S L Tan; S Tang; M S Taylor; J Tegner; S A Teichmann; H R Ueda; E van Nimwegen; R Verardo; C L Wei; K Yagi; H Yamanishi; E Zabarovsky; S Zhu; A Zimmer; W Hide; C Bult; S M Grimmond; R D Teasdale; E T Liu; V Brusic; J Quackenbush; C Wahlestedt; J S Mattick; D A Hume; C Kai; D Sasaki; Y Tomaru; S Fukuda; M Kanamori-Katayama; M Suzuki; J Aoki; T Arakawa; J Iida; K Imamura; M Itoh; T Kato; H Kawaji; N Kawagashira; T Kawashima; M Kojima; S Kondo; H Konno; K Nakano; N Ninomiya; T Nishio; M Okada; C Plessy; K Shibata; T Shiraki; S Suzuki; M Tagami; K Waki; A Watahiki; Y Okamura-Oho; H Suzuki; J Kawai; Y Hayashizaki
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

10.  Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.

Authors:  Z Culig; J Hoffmann; M Erdel; I E Eder; A Hobisch; A Hittmair; G Bartsch; G Utermann; M R Schneider; K Parczyk; H Klocker
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  122 in total

Review 1.  Minireview: Long noncoding RNAs: new "links" between gene expression and cellular outcomes in endocrinology.

Authors:  Miao Sun; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2013-07-24

Review 2.  Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology.

Authors:  Adam M Schmitt; Howard Y Chang
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

3.  Long non-coding RNA bladder cancer-associated transcript 2 contributes to disease progression, chemoresistance and poor survival of patients with colorectal cancer.

Authors:  Yongjun Ren; Caixia Zhao; Yi He; Hao Xu; Xuli Min
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

4.  Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients.

Authors:  Xin Huang; Cuifang Hao; Hongchu Bao; Meimei Wang; Huangguan Dai
Journal:  J Assist Reprod Genet       Date:  2015-12-09       Impact factor: 3.412

5.  Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.

Authors:  D Obinata; K Takayama; K Fujiwara; T Suzuki; S Tsutsumi; N Fukuda; H Nagase; T Fujimura; T Urano; Y Homma; H Aburatani; S Takahashi; S Inoue
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

6.  Characterization of DNA binding and pairing activities associated with the native SFPQ·NONO DNA repair protein complex.

Authors:  Durga Udayakumar; William S Dynan
Journal:  Biochem Biophys Res Commun       Date:  2015-05-18       Impact factor: 3.575

7.  Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Shuichi Tsutsumi; Tetsuya Fujimura; Satoru Takahashi; Yukio Homma; Tomohiko Urano; Hiroyuki Aburatani; Satoshi Inoue
Journal:  Mol Endocrinol       Date:  2014-12

Review 8.  From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease.

Authors:  Miao Sun; W Lee Kraus
Journal:  Endocr Rev       Date:  2014-11-26       Impact factor: 19.871

9.  Global analysis of biogenesis, stability and sub-cellular localization of lncRNAs mapping to intragenic regions of the human genome.

Authors:  Ana C Ayupe; Ana C Tahira; Lauren Camargo; Felipe C Beckedorff; Sergio Verjovski-Almeida; Eduardo M Reis
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 10.  Long non-coding RNAs as regulators of the endocrine system.

Authors:  Marko Knoll; Harvey F Lodish; Lei Sun
Journal:  Nat Rev Endocrinol       Date:  2015-01-06       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.